Article
Anticancer effects of sanguinarine in triple-negative breast cancer cells via apoptosis induction and cell cycle arrest
2022-05-09
Abstract excerpt
<title>Abstract</title> <p>Patients with triple-negative breast cancer (TNBC) are typically treated with non-targeted chemotherapeutic agents, and the late disease stages are known to be resistant to chemotherapy. Therefore, it is necessary to develop novel therapeutic agents that are safer and more effective for enhancing the outcomes of chemotherapeutic agents. The natural alkaloid sanguinarine (SANG) is a quat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0f0de7ce-6d00-57f9-bfb0-648e0d855a58
- DOI
- 10.21203/rs.3.rs-1602051/v1
